Key Highlights
- Century Health has raised an oversubscribed $5 million seed round, led by Origin Ventures, to expand its AI-powered clinical data platform and deepen collaborations with pharmaceutical and life sciences companies.
- The company’s CHARM platform has achieved 97% accuracy in clinical data abstraction, matching clinical expert judgment and enabling faster, research-ready real-world evidence generation.
- Century Health expanded its specialty provider data network 60x in the past year, supporting disease areas including neurology, nephrology, ophthalmology, respiratory, metabolic, and immunology.
Century Health has secured an oversubscribed $5 million seed funding round to accelerate the use of artificial intelligence in clinical data abstraction and real-world evidence generation.
The round was led by Origin Ventures, with participation from new investors including InnovateHealth Ventures, 25madison, and Next Play Ventures, alongside existing investors 2048 Ventures and Alumni Ventures.
The funding will support Century Health’s efforts to expand partnerships with pharmaceutical and life sciences companies, strengthen its specialty healthcare provider network, and scale its AI-driven clinical data infrastructure.
CHARM Platform Reaches 97% Accuracy
At the center of Century Health’s offering is its Century Health Abstraction & Retrieval Model (CHARM), an AI-powered platform designed to automate the curation and enrichment of fragmented clinical records.
The platform extracts valuable insights from unstructured healthcare data, including physician notes, radiology reports, and clinical documentation, to generate high-quality, research-ready datasets.
According to the company, CHARM now delivers 97% accuracy when benchmarked against clinical expert judgment, a critical standard used by pharmaceutical companies and research organizations when evaluating data for regulatory and therapeutic development purposes.
This level of precision addresses a long-standing challenge in clinical research, where manual data curation has traditionally slowed drug development timelines and increased operational costs.
Growing Demand for Real-World Clinical Data
Century Health enters the market at a time when demand for structured clinical data is accelerating. As AI adoption expands across drug discovery, patient stratification, and clinical trial design, pharmaceutical companies increasingly require proprietary, high-quality datasets to power research and improve treatment outcomes.
The company reported a 60-fold expansion in its provider data network over the past year, spanning specialties such as neurology, nephrology, ophthalmology, respiratory care, metabolic diseases, and immunology. Several top global pharmaceutical companies are already among its partners.
Prashant Shukla described Century Health’s platform as a key enabler of medical innovation, noting that structured clinical data serves as both the foundation for AI-driven discovery and the evidence required to validate therapies in the real world.
Expanding Healthcare Research Capabilities
Century Health plans to deepen disease-specific registries, strengthen pharmaceutical collaborations, and further enhance CHARM’s ability to manage complex data abstraction and harmonization.
According to co-founder and CEO Vish Srivastava, the company’s long-term goal is to make real-world clinical data more accessible, reliable, and actionable for researchers, healthcare providers, and life sciences organizations working to improve treatment outcomes and accelerate medical breakthroughs.
Read More news on Data Analytics.